헬스리아

비상장계속사업자

HEALTHRIA CO.,LTD.

강준혁

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

헬스리아

Business Reg. No. 1098608680 · CEO 강준혁

I.Investment Overview

Target헬스리아 (1098608680)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명헬스리아
영문명HEALTHRIA CO.,LTD.
대표자강준혁
사업자등록번호1098608680
법인등록번호1101113700732
설립일2007.06.19
종업원수10명

V.Workforce

10

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW182.22021101202240.1202318.9202419.32025
영업이익100M KRW76.2202133202211.120231.72025
순이익100M KRW44.220217.52022120231.42025
Item20252024202320222021
자산총계507.5억원525.8억원520.3억원532.1억원536.2억원
부채총계243.2억원262.9억원260억원272.7억원284.5억원
자본총계264.3억원262.9억원260.3억원259.3억원251.8억원
매출액19.3억원18.9억원40.1억원101억원182.2억원
영업이익1.7억원11.1억원33억원76.2억원
순이익1.4억원9,983만원7.5억원44.2억원

VII.Financial Ratios

FY2025 basis

9.03%

영업이익률

7.12%

순이익률

0.27%

ROA

0.52%

ROE

92.03%

부채비율

52.08%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

헬스리아 투심보고서 | Alpha Lenz